American Psychiatric Association Annual Meeting 2015
Extremist organizations attract vulnerable members by emphasizing victimization and sense of identity.
Mental health clinicians need to step up and educate the public, policymakers, and other health care providers on the importance of psychiatric care.
Fourth-year psychiatry residents had a more pessimistic outlook on their suicidal patients compared with first-year residents.
Study finds that high doses of the SNRI venlafaxine can alleviate depression and chronic pain in seniors.
Guidelines are needed in how patients and clinicians use social media to gain information about each other.
A small benefit was observed in children treated with antidepressants who had irritability, disruptive behaviors, and aggression.
The Binge Eating Disorder Screener-7 (BEDS-7) is a concise, patient-reported screening tool.
Hypermethylation in gene PPM1G is associated with behaviors that increase risk in adolescents for future alcohol-related problems.
Students who have sleep problems and have high stress have an elevated suicide risk.
Stigma and confidentiality are key concerns among psychiatrists in disclosing own mental illness.
Communication, location, and coordination are just three ways that psychiatrists can help improve collaboration with primary care.
Patients show greater depression improvement when CBT-focused Internet program added to treatment.
Patients who received TMS in addition to hospital stay, auxiliary therapy, and medication showed significant improvement in symptoms.
While many survivors still experience depression and anxiety, they also value life more and feel stronger.
APA past-president Carol A. Bernstein discusses how both male and female psychiatrists can help progress gender equality in psychiatry.
Ketamine and other drugs targeting the brain's NMDA receptors may benefit treatment-resistant depression.
Ongoing research indicates that biomarkers can predict the efficacy of an antipsychotic or potential side effects in a patient.
Some soldiers who would have met diagnosis under DSM-IV criteria are now diagnosed with adjustment disorder, which may impact their care.
New psychosocial and pharmacological treatments hold promise in better treating the disorders.
Using CBT to treat resistant depression requires more active care, but may be more beneficial for patients than usual care alone.
With growing calls for the use of cannabis in treating psychiatric conditions, psychiatrists need to be aware of the scientific evidence.
An evaluation of the CATIE trial finds high lipid levels may boost cognition in schizophrenia patients.
With gun violence on the rise and many mentally ill in the criminal justice system, psychiatrists should help to improve the situation.
Philip Muskin, MD, the American Psychiatric Association's scientific program committee chair, discusses the highlights of APA 2015.
Sign Up for Free e-newsletters
Check out what's trending
Psychiatry Advisor Articles
- Efficacy, Safety of Long-Term Ketamine Administration Still In Question
- Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants
- KCNQ Channel Potentiator Ezogabine Delivers Promising Results in Major Depressive Disorder
- Vulnerability to Psychosocial Disability in Psychosis
- FDA to Review Lumateperone for Treatment of Schizophrenia
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"